Xingwu Zhou

3.1k total citations · 3 hit papers
34 papers, 2.1k citations indexed

About

Xingwu Zhou is a scholar working on Biomedical Engineering, Immunology and Pharmaceutical Science. According to data from OpenAlex, Xingwu Zhou has authored 34 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 12 papers in Immunology and 9 papers in Pharmaceutical Science. Recurrent topics in Xingwu Zhou's work include Advancements in Transdermal Drug Delivery (9 papers), interferon and immune responses (7 papers) and 3D Printing in Biomedical Research (7 papers). Xingwu Zhou is often cited by papers focused on Advancements in Transdermal Drug Delivery (9 papers), interferon and immune responses (7 papers) and 3D Printing in Biomedical Research (7 papers). Xingwu Zhou collaborates with scholars based in United States, China and South Korea. Xingwu Zhou's co-authors include Wujin Sun, James J. Moon, Moyuan Qu, Xing Jiang, Yu L. Lei, Xiaoqi Sun, Xiaoyue Shi, Canran Wang, Yao Xu and Kyong Soo Park and has published in prestigious journals such as Proceedings of the National Academy of Sciences, ACS Nano and Nature Nanotechnology.

In The Last Decade

Xingwu Zhou

33 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy

2021 597 citations Xiaoqi Sun, Yu Zhang et al. Nature Nanotechnology profile →
A Dual‐Cross‐Linked Hydrogel Patch for Promoting Diabetic Wound Healing

2022 225 citations Moyuan Qu, Canran Wang et al. Small profile →
Strategies for the development of metalloimmunotherapies

2024 95 citations Xiaoqi Sun, Xingwu Zhou et al. Nature Biomedical Engineering profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xingwu Zhou United States	20	844	569	568	447	361	34	2.1k
Gaëlle Vandermeulen Belgium	26	475 0.6×	1.3k 2.2×	673 1.2×	695 1.6×	362 1.0×	48	2.8k
Thanh Loc Nguyen South Korea	17	729 0.9×	361 0.6×	432 0.8×	376 0.8×	203 0.6×	33	1.5k
Christian Wiraja Singapore	24	881 1.0×	762 1.3×	143 0.3×	319 0.7×	626 1.7×	56	2.2k
Anvay Ukidve United States	15	812 1.0×	869 1.5×	467 0.8×	658 1.5×	237 0.7×	17	2.2k
William Ho United States	20	547 0.6×	792 1.4×	241 0.4×	608 1.4×	99 0.3×	24	1.9k
Ruxia Han China	20	1.1k 1.3×	372 0.7×	191 0.3×	511 1.1×	137 0.4×	31	1.7k
Xue‐Qing Zhang United States	25	495 0.6×	873 1.5×	292 0.5×	511 1.1×	124 0.3×	37	2.1k
Jie Wen China	27	641 0.8×	995 1.7×	289 0.5×	829 1.9×	99 0.3×	84	2.7k
Nisarg J. Shah United States	20	1.1k 1.3×	431 0.8×	224 0.4×	599 1.3×	185 0.5×	39	2.1k
Kye Il Joo South Korea	18	376 0.4×	235 0.4×	142 0.3×	374 0.8×	161 0.4×	35	1.2k

Countries citing papers authored by Xingwu Zhou

Since Specialization

Citations

This map shows the geographic impact of Xingwu Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwu Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwu Zhou more than expected).

Fields of papers citing papers by Xingwu Zhou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwu Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwu Zhou. The network helps show where Xingwu Zhou may publish in the future.

Co-authorship network of co-authors of Xingwu Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwu Zhou. A scholar is included among the top collaborators of Xingwu Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwu Zhou. Xingwu Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

JU, H, Xingwu Zhou, Yusuf A. Haggag, et al.. (2025). Controlled delivery of STING agonist and manganese ion in injectable PLGA implants for enhanced cancer immunotherapy. Journal of Controlled Release. 389. 114410–114410.

Aikins, Marisa, Xiaoqi Sun, Hannah E. Dobson, et al.. (2024). STING-activating cyclic dinucleotide-manganese nanoparticles evoke robust immunity against acute myeloid leukemia. Journal of Controlled Release. 368. 768–779. 9 indexed citations

Cho, Young Seok, et al.. (2024). CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin. ACS Applied Materials & Interfaces. 16(14). 17129–17144. 17 indexed citations

Sun, Xiaoqi, Xuehui Huang, Kyong Soo Park, et al.. (2024). Self-Assembled STING-Activating Coordination Nanoparticles for Cancer Immunotherapy and Vaccine Applications. ACS Nano. 18(15). 10439–10453. 39 indexed citations

Qu, Moyuan, Weizhe Xu, Xingwu Zhou, et al.. (2024). An ROS‐Scavenging Treg‐Recruiting Hydrogel Patch for Diabetic Wound Healing. Advanced Functional Materials. 34(26). 51 indexed citations

Wu, Qiaoli, et al.. (2024). Interfacing hydrogel microneedle patch for diagnosis. Surfaces and Interfaces. 55. 105474–105474. 4 indexed citations

Sun, Xiaoqi, et al.. (2024). Strategies for the development of metalloimmunotherapies. Nature Biomedical Engineering. 8(9). 1073–1091. 95 indexed citations breakdown →

Li, Jiapeng, Shuxin Sun, Tristan Frum, et al.. (2024). Differential Bioactivation Profiles of Different GS-441524 Prodrugs in Cell and Mouse Models: ProTide Prodrugs with High Cell Permeability and Susceptibility to Cathepsin A Are More Efficient in Delivering Antiviral Active Metabolites to the Lung. Journal of Medicinal Chemistry. 67(9). 7470–7486. 1 indexed citations

Xu, Cheng, Hannah E. Dobson, Mengjie Yu, et al.. (2023). STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications. Journal of Controlled Release. 357. 84–93. 37 indexed citations

10.

Huang, Hui, Moyuan Qu, Yan Zhou, et al.. (2023). A microneedle patch for breast cancer screening via minimally invasive interstitial fluid sampling. Chemical Engineering Journal. 472. 145036–145036. 21 indexed citations

11.

Lin, Shixian, Xingwu Zhou, Fanwen Yang, et al.. (2023). Biodegradable double-network GelMA-ACNM hydrogel microneedles for transdermal drug delivery. Frontiers in Bioengineering and Biotechnology. 11. 1110604–1110604. 13 indexed citations

12.

Sun, Xiaoqi, Xingwu Zhou, Yu L. Lei, & James J. Moon. (2023). Unlocking the promise of systemic STING agonist for cancer immunotherapy. Journal of Controlled Release. 357. 417–421. 27 indexed citations

13.

Xue, Yumeng, Han‐Jun Kim, Junmin Lee, et al.. (2022). Co‐Electrospun Silk Fibroin and Gelatin Methacryloyl Sheet Seeded with Mesenchymal Stem Cells for Tendon Regeneration. Small. 18(21). e2107714–e2107714. 50 indexed citations

14.

Luo, Zhimin, Xingwu Zhou, Kalpana Mandal, et al.. (2021). Reconstructing the tumor architecture into organoids. Advanced Drug Delivery Reviews. 176. 113839–113839. 31 indexed citations

15.

Sun, Xiaoqi, Yu Zhang, Jiaqian Li, et al.. (2021). Amplifying STING activation by cyclic dinucleotide–manganese particles for local and systemic cancer metalloimmunotherapy. Nature Nanotechnology. 16(11). 1260–1270. 597 indexed citations breakdown →

16.

Qu, Moyuan, Canran Wang, Xingwu Zhou, et al.. (2021). Multi‐Dimensional Printing for Bone Tissue Engineering. Advanced Healthcare Materials. 10(11). e2001986–e2001986. 63 indexed citations

17.

Zhou, Xingwu, Xing Jiang, Moyuan Qu, et al.. (2020). Engineering Antiviral Vaccines. ACS Nano. 14(10). 12370–12389. 51 indexed citations

18.

Sun, Wujin, Jinqiang Wang, Quanyin Hu, et al.. (2020). CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation. Science Advances. 6(21). eaba2983–eaba2983. 103 indexed citations

19.

Zhu, Jixiang, Xingwu Zhou, Alberto Libanori, & Wujin Sun. (2020). Microneedle-based bioassays. Nanoscale Advances. 2(10). 4295–4304. 22 indexed citations

20.

Liu, Yan, Miao Zhou, Xingwu Zhou, et al.. (2020). Fabrication of Biomolecule-Loaded Composite Scaffolds Carried by Extracellular Matrix Hydrogel. Tissue Engineering Part A. 27(11-12). 796–805. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact